Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs
A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review
Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals
Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs
Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors
Navigating the Storm: 20 Defensive Dividend Stocks to Weather a Government Shutdown
Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule
Gilead Taps Veeva Vault CRM for Global Commercial Transformation
Gilead Sciences Pioneers Future of Manufacturing with New California Development Site
A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy
Walgreens Supercharges Specialty Pharmacy Network Amid Surging Demand for Life-Changing Therapies
First RSV shots, groundbreaking gene therapy among 2024 drugs to watch